Charles River Laboratories International, Inc. (CRL)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 03:06PM EDT. Market open.
| Previous Close | 225.49 |
| Open | 225.86 |
| Bid | 218.16 x 1200 |
| Ask | 218.68 x 800 |
| Day's Range | 217.44 - 226.76 |
| 52 Week Range | 203.37 - 460.21 |
| Volume | |
| Avg. Volume | 549,593 |
| Market Cap | 11.047B |
| Beta (5Y Monthly) | 1.27 |
| PE Ratio (TTM) | 26.50 |
| EPS (TTM) | 8.20 |
| Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 327.64 |
- Zacks
Charles River (CRL) Signs saRNA-Based Vaccine Manufacture Deal
Charles River's (CRL) industry knowledge in plasmid DNA production will benefit Ziphius Vaccines' early-stage saRNA manufacturing program.
- Simply Wall St.
Could The Market Be Wrong About Charles River Laboratories International, Inc. (NYSE:CRL) Given Its Attractive Financial Prospects?
It is hard to get excited after looking at Charles River Laboratories International's (NYSE:CRL) recent performance...
- Business Wire
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
WILMINGTON, Mass. & MACCLESFIELD, England, June 28, 2022--Charles River announces the opening of their High Quality Plasmid DNA Centre of Excellence at Bruntwood SciTech’s Alderley Park.
© 2022 Yahoo. All rights reserved.
